Brian Goff
Chief Executive Officer at Agios Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Agios Pharmaceuticals Inc., 3 years.
Agios Pharmaceuticals Inc.
Director · Chief Executive Officer
Intellia Therapeutics Inc.
Director
Chief executive roles
Agios Pharmaceuticals Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 13, 2024 | Intellia Therapeutics Inc. | Grant or award | +15,409 | — | — |
| Jun 5, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +25,527 | — | — |
| Jun 5, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −12,115 | $48.84 | $591,697 |
| Mar 5, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −4,156 | $32.57 | $135,361 |
| Mar 1, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +8,500 | — | — |
| Jan 24, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −7,635 | $21.64 | $165,221 |
| Jan 20, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +17,018 | — | — |
| Jan 9, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −12,066 | $22.99 | $277,397 |
| Jan 5, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +25,527 | — | — |
| Aug 8, 2023 | Agios Pharmaceuticals Inc. | Option exercise | +22,691 | — | — |
| Aug 8, 2023 | Agios Pharmaceuticals Inc. | Open-market sale | −10,178 | $25.48 | $259,335 |
| Jun 30, 2023 | Agios Pharmaceuticals Inc. | Open-market sale | −11,449 | $28.36 | $324,694 |
| Jun 28, 2023 | Agios Pharmaceuticals Inc. | Option exercise | +25,528 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.